Shift from Eradication to Control: An Adaptive Therapy Approach
This theoretical review explores the paradigm shift in oncology from maximum tolerated dose (MTD) eradication strategies to evolutionary-based adaptive therapy. By leveraging intratumoral competition between drug-sensitive and drug-resistant cell populations, adaptive therapy aims to maintain a stable tumor burden, delay treatment resistance, and improve long-term clinical outcomes.
Authors
- Rahma Al-zuhairi (ORCID: https://orcid.org/0009-0003-2242-0452)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24321896
- Primary Topic
- Mathematical Biology Tumor Growth
- Type
- preprint